WEN-JEN HWU to Neoplasm Invasiveness
This is a "connection" page, showing publications WEN-JEN HWU has written about Neoplasm Invasiveness.
Connection Strength
0.032
-
Neoadjuvant plus adjuvant dabrafenib and trametinib versus standard of care in patients with high-risk, surgically resectable melanoma: a single-centre, open-label, randomised, phase 2 trial. Lancet Oncol. 2018 02; 19(2):181-193.
Score: 0.022
-
The role of abdominoperineal resection as surgical therapy for anorectal melanoma. Ann Surg. 2006 Dec; 244(6):1012-7.
Score: 0.010